VENCLEXTA (venetoclax) tablets, for oral use Initial U.S. Approval: 2016
VENCLEXTA is a prescription medicine used:
- to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
- in combination with azacitidine, or decitabine, or low-dose cytarabine to treat adults with newly diagnosed acute myeloid leukemia (AML)
Brand Name: | VENCLEXTA |
Generic Name: | Venetoclax |
Strength: | • Tablets: 10 mg, 50 mg, 100 mg |
Manufacturer: | AbbVie Inc |
Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “VENCLEXTA (venetoclax) tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for VENCLEXTA (venetoclax) tablets price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.